Margreet G.E.M. Ausems

Author

Also Known As

Alex Henderson, Anja Wagner, Ans MW van den Ouweland, Ausems, M. G. E. M., Ausems, Margreet, Ausems, Margreet G E M, Ausems, Margreet G. E. M., Ausems, Margreet GEM, C. J. van Asperen, Carole Brewer

295

Publications

10.6K

Citations

H-Index

117

Concepts

All Affiliations

University Medical Center Utrecht The Netherlands Cancer Institute Radboud University Nijmegen Radboud University Medical Center University Medical Center Groningen

About

Margreet G.E.M. Ausems is an author at University Medical Center Utrecht specializing in medicine, genetic counseling, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	41	2K
2	Education	7	7	218
3	Health Sciences	3	3	280
4	Arts	2	2	49
5	Engineering	2	2	110

Margreet G.E.M. Ausems

134

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer Timothy R. Rebbeck, Nandita Mitra, Fei Wan, JAMA	2015	484
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study Elizabeth Bancroft, Elizabeth Page, Elena Castro, European Urology	2014	247
Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK) Anouk Pijpe, Nadine Andrieu, D. F. Easton, BMJ	2012	231
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers Elizabeth Page, Elizabeth Bancroft, Mark N. Brook, European Urology	2019	231
Microsatellite Instability, Immunohistochemistry, and Additional PMS2 Staining in Suspected Hereditary Nonpolyposis Colorectal Cancer Andrea E. van der Meulen‐de Jong, Marjo van Puijenbroek, Yvonne Hendriks, Clinical Cancer Research	2004	212
Improved overall survival after contralateral risk‐reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis B.A.M. Heemskerk-Gerritsen, Matti A. Rookus, Cora M. Aalfs, International Journal of Cancer Surgical OncologyBreast OncologyCancer EpidemiologyOverall SurvivalPbc Diagnosis	2014	208
Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction B.A.M. Heemskerk-Gerritsen, Caroline Seynaeve, C. J. van Asperen, JNCI Journal of the National Cancer Institute	2015	202
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers Bernadette A. M. Heemskerk‐Gerritsen, Agnes Jager, Linetta B. Koppert, Breast Cancer Research and Treatment	2019	181
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial Sepideh Saadatmand, H. Amarens Geuzinge, Emiel J. Rutgers, The Lancet Oncology Familial RiskMedical ImagingCancer DetectionCancer ScreeningGynecology	2019	168
Long-term yield of pancreatic cancer surveillance in high-risk individuals Kasper A. Overbeek, Iris J. M. Levink, Brechtje D.M. Koopmann, Gut	2021	153

Page 1